Versant Capital Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
Versant Capital Management's ABVX Position: Q3 2026 in Review
Versant Capital Management reduced its Abivax (ABVX) stake by 18% in Q3 2026, selling an estimated $4.82K and leaving 186 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2006.
Versant Capital Management first reported a position in ABVX in Q2 2026 and has held it in 2 quarters since. The position peaked at $30.1K in Q2 2026. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Versant Capital Management held 186 shares of Abivax worth $18.4K as of Q3 2026.
- Versant Capital Management sold 40 Abivax shares in Q3 2026, an estimated $4.82K.
- Abivax made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2006 holding.
- Versant Capital Management first reported a position in Abivax in Q2 2026 and has held it in 2 quarters since.
- Versant Capital Management's Abivax position peaked at $30.1K in Q2 2026.
- 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.